These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
385 related articles for article (PubMed ID: 24448212)
1. Glia and immune cell signaling in bipolar disorder: insights from neuropharmacology and molecular imaging to clinical application. Watkins CC; Sawa A; Pomper MG Transl Psychiatry; 2014 Jan; 4(1):e350. PubMed ID: 24448212 [TBL] [Abstract][Full Text] [Related]
2. The mood stabilizing properties of AF3581, a novel potent GSK-3β inhibitor. Capurro V; Lanfranco M; Summa M; Porceddu PF; Ciampoli M; Margaroli N; Durando L; Garrone B; Ombrato R; Tongiani S; Reggiani A Biomed Pharmacother; 2020 Aug; 128():110249. PubMed ID: 32470749 [TBL] [Abstract][Full Text] [Related]
3. Glycogen Synthase Kinase-3β as a Putative Therapeutic Target for Bipolar Disorder. Dandekar MP; Valvassori SS; Dal-Pont GC; Quevedo J Curr Drug Metab; 2018; 19(8):663-673. PubMed ID: 29283064 [TBL] [Abstract][Full Text] [Related]
4. Kinins and microglial responses in bipolar disorder: a neuroinflammation hypothesis. Naaldijk YM; Bittencourt MC; Sack U; Ulrich H Biol Chem; 2016 Apr; 397(4):283-96. PubMed ID: 26859499 [TBL] [Abstract][Full Text] [Related]
5. Structure-based design leads to the identification of lithium mimetics that block mania-like effects in rodents. possible new GSK-3beta therapies for bipolar disorders. Kozikowski AP; Gaisina IN; Yuan H; Petukhov PA; Blond SY; Fedolak A; Caldarone B; McGonigle P J Am Chem Soc; 2007 Jul; 129(26):8328-32. PubMed ID: 17552518 [TBL] [Abstract][Full Text] [Related]
6. The Wnt signaling pathway in bipolar disorder. Gould TD; Manji HK Neuroscientist; 2002 Oct; 8(5):497-511. PubMed ID: 12374432 [TBL] [Abstract][Full Text] [Related]
7. Glycogen synthase kinase-3β inactivation inhibits tumor necrosis factor-α production in microglia by modulating nuclear factor κB and MLK3/JNK signaling cascades. Wang MJ; Huang HY; Chen WF; Chang HF; Kuo JS J Neuroinflammation; 2010 Dec; 7():99. PubMed ID: 21194439 [TBL] [Abstract][Full Text] [Related]
8. Lithium and valproate act on the GSK-3β signaling pathway to reverse manic-like behavior in an animal model of mania induced by ouabain. Valvassori SS; Dal-Pont GC; Resende WR; Jornada LK; Peterle BR; Machado AG; Farias HR; de Souza CT; Carvalho AF; Quevedo J Neuropharmacology; 2017 May; 117():447-459. PubMed ID: 27789311 [TBL] [Abstract][Full Text] [Related]
9. Translating neurotrophic and cellular plasticity: from pathophysiology to improved therapeutics for bipolar disorder. Soeiro-de-Souza MG; Dias VV; Figueira ML; Forlenza OV; Gattaz WF; Zarate CA; Machado-Vieira R Acta Psychiatr Scand; 2012 Nov; 126(5):332-41. PubMed ID: 22676371 [TBL] [Abstract][Full Text] [Related]
10. Deficiency of diacylglycerol kinase η induces lithium-sensitive mania-like behavior. Isozaki T; Komenoi S; Lu Q; Usuki T; Tomokata S; Matsutomo D; Sakai H; Bando K; Kiyonari H; Sakane F J Neurochem; 2016 Aug; 138(3):448-56. PubMed ID: 27167678 [TBL] [Abstract][Full Text] [Related]
11. Postmortem evidence of brain inflammatory markers in bipolar disorder: a systematic review. Giridharan VV; Sayana P; Pinjari OF; Ahmad N; da Rosa MI; Quevedo J; Barichello T Mol Psychiatry; 2020 Jan; 25(1):94-113. PubMed ID: 31249382 [TBL] [Abstract][Full Text] [Related]
12. Valproate regulates GSK-3-mediated axonal remodeling and synapsin I clustering in developing neurons. Hall AC; Brennan A; Goold RG; Cleverley K; Lucas FR; Gordon-Weeks PR; Salinas PC Mol Cell Neurosci; 2002 Jun; 20(2):257-70. PubMed ID: 12093158 [TBL] [Abstract][Full Text] [Related]
13. Genetic influences on response to mood stabilizers in bipolar disorder: current status of knowledge. Rybakowski JK CNS Drugs; 2013 Mar; 27(3):165-73. PubMed ID: 23378337 [TBL] [Abstract][Full Text] [Related]
14. [Mood stabilizers--past, present and future]. Sümegi A Neuropsychopharmacol Hung; 2008 Mar; 10(1):31-42. PubMed ID: 18771018 [TBL] [Abstract][Full Text] [Related]
15. The role of Wnt signaling and its interaction with diverse mechanisms of cellular apoptosis in the pathophysiology of bipolar disorder. Hu LW; Kawamoto EM; Brietzke E; Scavone C; Lafer B Prog Neuropsychopharmacol Biol Psychiatry; 2011 Jan; 35(1):11-7. PubMed ID: 20828594 [TBL] [Abstract][Full Text] [Related]
16. Glycogen synthase kinase-3β activity and cognitive functioning in patients with bipolar I disorder. Munkholm K; Miskowiak KW; Jacoby AS; Vinberg M; Leme Talib L; Gattaz WF; Kessing LV Eur Neuropsychopharmacol; 2018 Mar; 28(3):361-368. PubMed ID: 29433844 [TBL] [Abstract][Full Text] [Related]